These findings suggest that this miRNA potentially functions as a tumor suppressor in HCC by inhibiting DNMT3B and the LATS1-associated Hippo-YAP/TAZ signaling pathway, representing a novel potential therapeutic target for HCC. The gene discussed is LATS1; the disease is hepatocellular carcinoma.